Sarah Brown’s Post

During the recent Value-Based Payment Summit, Dr. Amy Schuerman-Gen, VP of clinical operations for DaVita Integrated Kidney Care (IKC), underscored the importance of creating improved care experiences for patients as the goal of value-based care. "For me, this transformation is all about our patients," she said. "Keeping them at the center of what we do is paramount.” Read more about the panel discussion and the important work DaVita IKC is doing: https://ow.ly/MOCt30sz3C4

During the recent Value-Based Payment Summit, Dr. Amy Schuerman-Gen, VP of clinical operations for DaVita Integrated Kidney Care (IKC), underscored the importance of creating improved care experiences for patients as the goal of value-based care. "For me, this transformation is all about our patients," she said. "Keeping them at the center of what we do is paramount.” Read more about the panel discussion and the important work DaVita IKC is doing: https://ow.ly/vTzu30szyOH

During the recent Value-Based Payment Summit, Dr. Amy Schuerman-Gen, VP of clinical operations for DaVita Integrated Kidney Care (IKC), underscored the importance of creating improved care experiences for patients as the goal of value-based care. "For me, this transformation is all about our patients," she said. "Keeping them at the center of what we do is paramount.” Read more about the panel discussion and the important work DaVita IKC is doing: https://ow.ly/XyMs30syW99

From the first digital triage to full recovery, Pathways is designed to guide more MSK patients to the appropriate level of care, helping them return to the activities they love. Initial assessments capture patients early in their recovery journey, building a deep understanding of their pain and capabilities. With this info, providers can personalize the right clinical program to meet their needs. Pathways takes it from there, with a patient-centered design that ensures patients keep coming back. Discover how a partnership with MedBridge can bring provider-driven MSK care to more patients than ever before: https://lnkd.in/gsPnM_aG

I'm looking to speak with IBD healthcare professionals about your experience of caring for Crohn's and UC patients during the COVID pandemic. Did it affect the frequency and type of patient presentations, also what learnings has it brought to your ongoing practice? It's for my own piece on patient and clinical perspectives on IBD care during COVID. If you're interested in talking with me, please do get in touch. Thanks. #ibd #inflammatoryboweldisease #crohns #crohnsdisease #ulcerativecolitis

Dr. David Roer MD FACP FASN, chief medical officer emeritus for DaVita IKC, recently joined Dr. Nathan Moore of BJC on stage at The Health Management Academy 2024 to discuss how defragmentation of care in complex patients with end-stage kidney disease (ESKD) can improve clinical outcomes. This discussion touched on the value of integrating these concepts into provider-to-provider value-based structures. To learn more about the work discussed, visit https://lnkd.in/eg8iEzuQ  #TransformingHealthcare

148,000 DOs, including many #osteopathic IM physicians, serve communities nationwide through whole-person care. Celebrate #NOMWeek with ACOI and our partners by learning about the contributions of those in our rapidly growing DO profession who are making a positive difference for patients every day: https://ow.ly/IIlC50RiNkY #NOMWeek24 #osteopathicmedicine #internalmedicine #internalmedicineresident #internalmedicineresidency #internalmedicineresidents

Today is International Clinical Trials Day, a day to highlight the importance of clinical trials and celebrate those who bring hope to millions.   From the professionals who advance clinical research and shepherd those trials to the heroic patients, all of us at Pliant recognize and celebrate the critical role each of you plays to advance research and improve patient healthcare outcomes. #ClinicalTrialsDay #CTD2024

Yesterday our CEO Dr Thomas Oakley spoke at the HSJ Events Modernising Diagnostics Forum panel on embedding community diagnostics.   Speaking on the panel, Oakley discussed the need to think about how we can better utilise community diagnostic centre (#CDC) outputs to impact wider service delivery and patient waitlists as we try to build on the successes of the CDC programme.   Whilst CDCs are increasing diagnostic capacity, to turn those tests into decisions, CDC outputs need to be embedded into patient journeys; supported by the right digital infrastructure.   Bleepa allows you to integrate CDCs into broader clinical workflows, connecting primary and secondary care settings and giving regional oversight of the patient journey.   Find out more about how we have been working with CDCs to reduce wait times and outpatient requirements by enabling clinicians to work more flexibly with powerful communication and referral tools, without the need for additional staff.  

Patients with Cholangiocarcinoma: As part of our ongoing commitment to promoting patient-centered care for cholangiocarcinoma, we are reaching out to invite you to participate in an important survey we have launched with NYU Langone Health. Your experience as a patient with #cholangiocarcinoma is invaluable to us, and we believe that your voice can significantly contribute to the enhancement of care not only for yourself but also for future patients facing similar challenges. By sharing your insights on either participating in or your thoughts on participating in phase 1 clinical trials, you can help us better understand patients' needs, concerns, and preferences. Access the survey here: https://lnkd.in/gZ5cDH5b The survey is open until May 15. Your feedback will directly inform efforts to refine and optimize clinical trial protocols, ensuring they align more closely with realities, and responses will be shared at the upcoming ASCO meeting with a publication to follow.